Lazard Capital Downgrades Transcept Pharmaceuticals To Neutral

Symbols: TSPT
Share

Lazard Capital has downgraded Transcept Pharmaceuticals (NASDAQ: TSPT) from Buy to Neutral.


 
 
< Previous
Raymond James Downgrades SkyWest To Market Perform
Next >
Capital One Downgrades Petrohawk Energy To Neutral
Share
Printer-friendly version
Send to friend
We're Loving

Benzinga's Premium Memberships

Benzinga's News Delivered Free

Brain Trust